Adeka (4401) Q4 2026 earnings summary

Executive summary

• FY2025 net sales, operating profit, ordinary profit and profit attributable to owners of parent all reached records; FY2026 targets a third consecutive year of record sales and profit.

• Life Science led sales growth; profit rebounds in Environmental Materials and Life Science offset declines in Polymer Additives and Semiconductor Materials.

Financial highlights

• Net sales were ¥416,563 million (+2.3% YoY), operating profit ¥41,614 million (+1.5%), ordinary profit ¥42,772 million (+8.7%) and parent-attributable profit ¥27,866 million (+11.4%).

• Basic EPS was ¥277.95, up from ¥245.55; comprehensive income was ¥47,507 million (+87.3%).

• Operating profit benefited from sales volume (+¥5.9 billion), offset by fixed costs (-¥4.2 billion) and negative net pricing and FX impacts.

• Operating cash flow was ¥40,612 million (-12.2%); investing and financing cash flows were -¥30,078 million and -¥35,301 million, respectively.

Outlook and guidance

• FY2026 forecast: net sales ¥453 billion, operating profit ¥46.8 billion, ordinary profit ¥46.6 billion, parent-attributable profit ¥28.8 billion and EPS ¥294.3.

• Forecasts project YoY sales and operating profit growth in every segment; Middle East impacts are excluded.

• Semiconductor Materials marginal profit is expected to grow faster than fixed costs, supporting operating profit growth.